Kura Oncology Inc Capital Reinvestment Ratio

Latest as of December 2025: 0.02x

Kura Oncology Inc capital reinvestment ratio. Kura Oncology Inc (KURA) has a Capital Reinvestment Ratio of 0.02x as of December 2025, meaning it reinvests 0% of its operating cash flow ($117.27 Million) in capital expenditures ($2.32 Million). Check Kura Oncology Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.02x

Capex / Operating Cash Flow

Operating Cash Flow

$117.27 Million

USD

Capital Expenditures

$2.32 Million

USD

Data as of

Dec 2025

Most recent filing

Capital Reinvestment Ratio of Kura Oncology Inc (2024–2024)

Capital reinvestment ratio of Kura Oncology Inc from 2024 to 2024. This chart tracks Kura Oncology Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore net asset momentum of Kura Oncology Inc to track the company's year-over-year net asset growth rate.

Kura Oncology Inc Capital Reinvestment Ratio by Year (2024–2024)

Kura Oncology Inc capital reinvestment ratio by year from 2024 to 2024. For the full cash flow conversion analysis, see KURA cash flow metrics.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change
2024	0.00x	$134.32 Million	$472.00K	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow